PPE Advantage Wet Wipes by Zhejiang iColor Biotech Co., Ltd PPE Advantage Wet Wipes

PPE Advantage Wet Wipes by

Drug Labeling and Warnings

PPE Advantage Wet Wipes by is a Otc medication manufactured, distributed, or labeled by Zhejiang iColor Biotech Co., Ltd. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

PPE ADVANTAGE WET WIPES- benzalkonium chloride gel 
Zhejiang iColor Biotech Co., Ltd

----------

PPE Advantage Wet Wipes

Drug Facts

Active ingredient

Benzalkonium Chloride 0.1%

Purpose

Antibacterial

Uses

  • Hand sanitizer to help reduce bacteria on the skin

Warnings

For external use only

When using this product

do not use in or near eyes, ears, and mouth. In case of contact with eyes, rinse eyes thoroughly with water.

Stop use and ask a doctor

if irritation or rash appears on the skin.

Keep out of reach of children.

If swallowed, get medical help or contact Poison Control Center right away.

Directions

  • Wet hands thoroughly with product and allow to dry.
  • Discard wipe in trash receptacle after use. Do not flush.
  • Children under 6 years of age should be supervised by adult when applying this product.

Inactive ingredients

Ethylhexylglycerin, Glycerin, Phenoxyethanol, Polyaminopropyl biguanide, Propylene Glycol, Purified water, Fragrance

Questions or Comments?

212-551-2657

Package Labeling:100ct

Bottle

Package Labeling:220ct

Bottle2

PPE ADVANTAGE WET WIPES 
benzalkonium chloride gel
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC: 74934-046
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7) (BENZALKONIUM - UNII:7N6JUD5X6Y) BENZALKONIUM CHLORIDE1 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)  
GLYCERIN (UNII: PDC6A3C0OX)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
POLYAMINOPROPYL BIGUANIDE (UNII: DT9D8Z79ET)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 74934-046-01100 in 1 CANISTER08/10/202001/31/2026
14.2 mL in 1 PATCH; Type 2: Prefilled Drug Delivery Device/System (syringe, patch, etc.)
2NDC: 74934-046-02220 in 1 CANISTER08/10/202001/31/2026
24.2 mL in 1 PATCH; Type 2: Prefilled Drug Delivery Device/System (syringe, patch, etc.)
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph Drug505G(a)(3)08/10/202001/31/2026
Labeler - Zhejiang iColor Biotech Co., Ltd (554528308)

Revised: 1/2024